Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 293-297

  Dokianakis, D N ^a   Varras, M N ^a   Papaefthimiou, M ^b   Apostolopoulou, J ^b   Simiakaki, H ^b   Diakomanolis, E ^b   Spandidos, D A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

Ascites; Ovarian neoplasms; PCR; Peritoneal washings; Ras oncogenes

Indexed keywords

ARTICLE; ASCITES; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE ACTIVATION; HUMAN; HUMAN TISSUE; ONCOGENE RAS; OVARY CARCINOMA; PERITONEAL FLUID; POINT MUTATION;

ADENOCARCINOMA; ASCITES; ASCITIC FLUID; CYSTADENOMA; FEMALE; GENES, RAS; HUMANS; OVARIAN NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SENSITIVITY AND SPECIFICITY;

EID: 0032879120     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006611220434     Document Type: Article

References (20)

1. DiSaia PJ, Creasman WT (ed.) Clinical Gynaecologic Oncology 1997; Mosby-Year Book, Inc.
2. Gershenson DM, Tortolero-Luna G, Malpica A et al. Ovarian intraepithelial neoplasia and ovarian cancer. In Mitchell MF, Scottenfeld D, Hong WK (eds): Gynecologic Cancer Prevention. Obstetrics and Gynecology Clinics of North America 1996; Vol. 23, 475-543.
3. Petterson F. Annual report on the results of treatment in gynaecological cancers. International Federation of Gynaecology and Obstetrics. Int J Gynecol Obstetrics 1991; 21: 238-9.
4. Pronk GJ, Bos JL. The role of p21 ras in receptor tyrosine kinase signalling. Biochem Biophys Acta 1994; 1198: 131-47.
5. Dokianakis DN, Sourvinos G, Sakkas S et al. Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Oncol Rep 1998; 5: 1195-8.
6. Koffa M, Malamou-Mitsi V, Agnantis NJ, Spandidos DA. Mutational activation of K-ras oncogene in human breast tumours. Int J Oncol 1994; 4: 573-6.
7. Skalkeas GD, Spandidos DA, Kostakis A et al. K-ras oncogene mutations in neoplasms of kidney transplanted patients: preliminary results with a new technique. Anticancer Res 1991; 11: 2091-4.
8. Kim TY, Bang YJ, Kim WS et al. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype. Anticancer Res 1997; 17: 1335-40.
9. Mulder MP, Keijzer W, Boot AJM et al. Activated ras genes in human seminomas: evidence for tumour heterogeneity. Oncogene 1989; 4: 1345-51.
10. Teneriello MG, Ebina M, Linnoila RI et al. p53 and Ki-ras gene mutations in epithelial ovarian neoplasmas. Cancer Res 1993; 53: 3103-8.
11. Varras MN, Sourvinos G, Diakomanolis E et al. Detection and clinical correlations of ras gene mutations in human ovarian tumors. Oncology 1999; 56: 89-96.
12. Koffa M, Simiakaki H, Ergazaki M. HPV detection in stained cytological cervical specimens and correlation with cytology and histology. Oncology Rep 1995; 2: 1085-8.
13. Spandidos DA, Liloglou T, Arvanitis D, Gourtsoyannis NC. ras gene activation in human small intestinal tumors. Int J Oncol 1993; 2: 513-518.
14. Varras MN, Koffa M, Koumantakis E. Ras gene mutations in human endometrial carcinoma, Oncology 1996; 53: 505-10.
15. Yanez L, Groffen J, Valenzuela DM. c-K-ras mutations in human carcinomas occur preferentially in codon 12. Oncogene 1987; 1: 315-8.
16. Kiaris H, Spandidos DA. Mutations of ras genes in human tumours (review). Int J Oncol 1995; 7: 413-21.
17. Zuna R, Mitchell M, Molick K, Weijchert W, Cytologic correlation of peritoneal washing cytology in gynecological disease. Acta Cytol 1989; 33: 327-36.
18. Jones MA, Hitchcox S, D'Ascanio P et al. Flow cytometry DNA analysis versus cytology in the evaluation of peritoneal fluids. Gynecol Oncol 1991;43: 226-323.
19. Kehoe S, Ward K, Luesley D, Chan KK. The application of flow cytometric DNA analysis in detecting the presence of malignant cells in ovarian carcinoma peritoneal fluids. Br J Obstetrics Gynaecol 1995; 102: 656-9.
20. Barnebei VM, Miller DS, Bauer KD et al. Flow cytometric evaluation of epithelial ovarian cancer. Am J Obstetrics Gynecol 1990; 162: 1584-90.